메뉴 건너뛰기




Volumn , Issue , 2012, Pages 59-77

FDA Approach to Pediatric Testing

Author keywords

BPCA, and FD C Act, for prescription drugs and medical devices; Drug prescribers to understand biologicals, Animal Teratogens May Not Be Human Teratogens; Pediatric, FDA rule "1994 Rule" ensuring new drugs with pediatric labelings

Indexed keywords


EID: 84886118890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118168226.ch4     Document Type: Chapter
Times cited : (2)

References (32)
  • 1
    • 84886119679 scopus 로고    scopus 로고
    • A History of the FDA@ FDA.gov
    • A History of the FDA@ FDA.gov, http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm054819.htm
  • 2
    • 84886165414 scopus 로고    scopus 로고
    • http:www.thalidomidesociety.co.uk/thalhistory.htm
  • 3
    • 0343176197 scopus 로고
    • Drug embryopathy: the thalidomide story
    • Kelsey FO. Drug embryopathy: the thalidomide story. MD State Med J 1963;12: 594-597
    • (1963) MD State Med J , vol.12 , pp. 594-597
    • Kelsey, F.O.1
  • 4
    • 0037108228 scopus 로고    scopus 로고
    • Policy developments in regulatory approval
    • Temple R. Policy developments in regulatory approval. Stat Med 2002;21:2939-2948
    • (2002) Stat Med , vol.21 , pp. 2939-2948
    • Temple, R.1
  • 5
    • 84886158975 scopus 로고    scopus 로고
    • Pediatric Rule, Federal Register, 59FR64240; 1994 Dec 13
    • Pediatric Rule, Federal Register, 59FR64240; 1994 Dec 13
  • 6
    • 0000358397 scopus 로고    scopus 로고
    • The Pediatric rule, regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients, final rule.
    • Anon., The Pediatric rule, regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients, final rule. Fed Regist 1998;63(231):66632-66672
    • (1998) Fed Regist , vol.63 , Issue.231 , pp. 66632-66672
    • Anon1
  • 7
    • 84886226092 scopus 로고    scopus 로고
    • Pediatric Research Equity Act (PREA). Available at December 2003
    • Pediatric Research Equity Act (PREA). Available at http://www.fda.gov/opacom/ laws.pres.html. December 2003
  • 8
    • 84886119078 scopus 로고    scopus 로고
    • FDAMA. Pub. S.1789, Best pharmaceuticals for children Act; 21 USC 355a. 2001 Jan 3
    • FDAMA. Pub. S.1789, Best pharmaceuticals for children Act; 21 USC 355a. 2001 Jan 3
  • 9
    • 84886153958 scopus 로고    scopus 로고
    • Presentation, pediatric market US. Information on file at tufts center for pediatric development. 2003 March
    • Durant D. Presentation, pediatric market US. Information on file at tufts center for pediatric development. 2003 March
    • Durant, D.1
  • 10
    • 57649147435 scopus 로고    scopus 로고
    • Global pediatric drug sales to top $46 Billion.
    • Anon., Global pediatric drug sales to top $46 Billion. PhRMA Mark Lett 2006;33(4):16
    • (2006) PhRMA Mark Lett , vol.33 , Issue.4 , pp. 16
    • Anon1
  • 11
    • 57649172104 scopus 로고    scopus 로고
    • The trials of youth, bringing children into clinical research.
    • Myshko D. The trials of youth, bringing children into clinical research. Pharmavoice 2003;3(9):42-48
    • (2003) Pharmavoice , vol.3 , Issue.9 , pp. 42-48
    • Myshko, D.1
  • 13
    • 0003680152 scopus 로고    scopus 로고
    • The pharmacological basis of therapeutics.
    • 11th ed. New York: McGraw-Hill Medical Publishing Division;
    • Goodman and Gilman's. The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Medical Publishing Division; 2006. pp. 1181-1182
    • (2006) , pp. 1181-1182
    • Goodman1    Gilman's2
  • 14
    • 0003680152 scopus 로고    scopus 로고
    • The pharmacological basis of therapeutics.
    • 10th ed. New York: McGraw-Hill Medical Publishing Division;
    • Goodman and Gilman's. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill Medical Publishing Division; 2001. p. 1245
    • (2001) , pp. 1245
    • Goodman1    Gilman's2
  • 15
    • 84886181938 scopus 로고    scopus 로고
    • Washington (DC): American Pharmaceutical Association
    • Handbook of pharmaceutical excipients. 3rd ed. Washington (DC): American Pharmaceutical Association; 2000. p. 42
    • (2000) Handbook of pharmaceutical excipients. 3rd ed , pp. 42
  • 16
    • 0242681944 scopus 로고    scopus 로고
    • History of Excipient Safety and Toxicity,
    • In: Weiner ML, Kotkoskie LA, editors, Excipient Toxicity and Safety, Marcel Dekker, Inc., New York, N.Y.,
    • Winek, C., History of Excipient Safety and Toxicity, In: Weiner ML, Kotkoskie LA, editors, Excipient Toxicity and Safety, Marcel Dekker, Inc., New York, N.Y., Vol. 103, pps. 59-72
    • , vol.103 , pp. 59-72
    • Winek, C.1
  • 17
    • 84886151861 scopus 로고    scopus 로고
    • FDA Part 15 Hearing on O-T-C Drugs, Docket #00N-1256, June 28, 1972
    • Greene MF. FDA Part 15 Hearing on O-T-C Drugs, Docket #00N-1256, June 28, 1972
    • Greene, M.F.1
  • 18
    • 84886123647 scopus 로고    scopus 로고
    • FDA Introduction to Total Drug Quality, DHEW Publication 74-3006, DHEW/PHS/FDA, 1973
    • Anon., FDA Introduction to Total Drug Quality, DHEW Publication 74-3006, DHEW/PHS/FDA, 1973
    • Anon1
  • 19
    • 84886172988 scopus 로고
    • Redbook II. Toxicological principles for the safety assessment of direct food additives and color additives used in food. Center for Food Safety and Applied Nutition, US Food and Drug Administration; , U.S. Department of Commerce, National Technical Information Service, Springfield, VA 22161, PB 83-170696
    • Redbook II. Toxicological principles for the safety assessment of direct food additives and color additives used in food. Center for Food Safety and Applied Nutition, US Food and Drug Administration; 1993, U.S. Department of Commerce, National Technical Information Service, Springfield, VA 22161, PB 83-170696
    • (1993)
  • 23
    • 84886105264 scopus 로고    scopus 로고
    • Reviewer Guidance, Integration of Study Results to Assess Concerns about Human Reproductive and Developmental Toxicities. 2001 Oct. Copies may be available from the Drug Information Branch (HFD-210), CDER
    • Anon., Reviewer Guidance, Integration of Study Results to Assess Concerns about Human Reproductive and Developmental Toxicities. 2001 Oct. Copies may be available from the Drug Information Branch (HFD-210), CDER
    • Anon1
  • 24
    • 84886122033 scopus 로고    scopus 로고
    • FDA/CDER Guidance for Industry. Nonclinical safety evaluation of pediatric drug products. 2006 Feb. Available at
    • FDA/CDER Guidance for Industry. Nonclinical safety evaluation of pediatric drug products. 2006 Feb. Available at http://www.fda.gov/cder/guidance/index.htm
  • 25
    • 84886118075 scopus 로고    scopus 로고
    • FDA/CBER Guidance for Industry. Premarket assessment of pediatric medical devices. 2004 May. Available at
    • FDA/CBER Guidance for Industry. Premarket assessment of pediatric medical devices. 2004 May. Available at http://www.fda.gov/BiologicsBloodVaccines/default.htm
  • 26
    • 84886205137 scopus 로고    scopus 로고
    • FDA CDER/CBER Guidance for Industry. E11-clinical investigation of medicinal products in the pediatric population 2000. Available at
    • FDA CDER/CBER Guidance for Industry. E11-clinical investigation of medicinal products in the pediatric population 2000. Available at http://www.fda.gov/cder/guidance/- index.htm
  • 27
    • 84886204815 scopus 로고    scopus 로고
    • ICH.
    • ICH. http://www.ich.org
  • 28
    • 84886124912 scopus 로고    scopus 로고
    • ICH S5A
    • ICH S5A, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm065007.htm
  • 29
    • 0023544856 scopus 로고
    • Teratological research using in vitro systems, V Non-mammalian model systems.
    • Collins TF. Teratological research using in vitro systems, V. Non-mammalian model systems. Environ Health Perspect 1987;72:237-249
    • (1987) Environ Health Perspect , vol.72 , pp. 237-249
    • Collins, T.F.1
  • 31
    • 84886140089 scopus 로고    scopus 로고
    • ICH E11
    • ICH E11, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm065004.htm
  • 32
    • 84886218842 scopus 로고    scopus 로고
    • Presentation: global pediatric drug development and the European pediatric initiative: A brief overview. FDA; 2007 Dec.
    • Murphy D. Presentation: global pediatric drug development and the European pediatric initiative: A brief overview. FDA; 2007 Dec.
    • Murphy, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.